Five-time "Tour de France" champion Lance Armstrong--and members
of the Bristol-Myers Squibb "Tour of Hope"--recently made a
special stop at the National Institutes of Health, to raise awareness
of the importance of cancer research and participation in clinical trials.
Speaking at a press briefing, Armstrong--a cancer survivor--related a
story about a reunion of over 400 survivors of testicular cancer...
"In the group, was a guy named John Cleland, who was the very first
patient to ever be treated with platinum-based chemotherapy. He had failed
three different other drugs--and, at some point, Doctor Larry Einhorn (NCI)
said, 'why don't we try this platinum stuff?' And, the guy is still alive
today--still runs marathons, still runs every day. If it wasn't for that
stuff, and it wasn't for John [sic]--you know, his willingness to go on
a clinical trial, and to pave the way, you know, really to be a pioneer--then
we never would have had a kid from Texas on a bike that wins a bike race
Other cyclists participating in the "Tour of Hope's" 26-member
squad are cancer survivors, caregivers, physicians, nurses, and researchers.
To learn more about the "Tour", go to www.tourofhope.org.
This is Calvin Jackson, the National Institutes of Health, Bethesda, Maryland.